The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Breast cancer mortality among users of cholesterol-lowering drugs.
Teemu Johannes Murtola
Stock Ownership - Orion Corporation
Other Remuneration - Astellas Pharma; Ferring
Kala Visvanathan
No relevant relationships to disclose
Miia Artama
No relevant relationships to disclose
Harri Vainio
No relevant relationships to disclose
Eero Pukkala
No relevant relationships to disclose